23/10/2023

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

23/10/2023

Oct 23, 2023, 17:15 | Insight
María Natalia Gandur Quiroga: Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991 study results.
Quoting María Natalia Gandur Quiroga on X/Twitter: “Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991…
Oct 23, 2023, 15:51 | Blog
Princess Dina Mired: As a mother of a cancer survivor, my heart goes out to all the innocent children in Gazza who now have to wait whilst cancer is ravaging their tiny bodies since there is no more chemotherapy
Oct 23, 2023, 15:40 | Blog
Erika Hamilton: Not all AEs are equal...
Erika Hamilton shared a post by Hope Rugo on X/Twitter: “Not all AEs are equal…
Oct 23, 2023, 15:35 | Blog
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA…
Oct 23, 2023, 15:26 | Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Oct 23, 2023, 15:24 | Insight
Why radiotherapy with concomitant chemotherapy is an excellent option for bladder preservation in bladder cancer patients
Pierre Blanchard, Full Professor of Radiation Oncology at Gustave Roussy Cancer Center, posted on his…
Oct 23, 2023, 15:23 | Drugs
Pashtoon Kasi: So excited to move the field forward with novel therapies for patients with pMMR/MSS Colorectal Cancer
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, shared on his Twitter:…
Oct 23, 2023, 13:31 | Drugs
At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma
Agenus shared on their LinkedIn page: "At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational…
Oct 23, 2023, 13:26 | Insight
Marcelo Corassa: Great presentation by the amazing Jarushka Naidoo on the promises and pitfalls of neoadjuvant therapy for NSCLC
Marcelo Corassa, Medical oncologist and Clinical Researcher at Beneficência Portuguesa de São Paulo, shared on…
Oct 23, 2023, 13:21 | Career
Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes
Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on…
All: 22 Posts: 11 - 20
Special Coverage